Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 18;12(14):e030495.
doi: 10.1161/JAHA.123.030495. Epub 2023 Jul 8.

So Much to Say on the Best of What's Around Regarding Sodium-Glucose Cotransporter-2 Inhibitors in Acute Myocardial Infarction

Jairo T Nunes  1   2   3   4 , Jacob A Udell  1   2   3   4   5
Affiliations
Editorial

So Much to Say on the Best of What's Around Regarding Sodium-Glucose Cotransporter-2 Inhibitors in Acute Myocardial Infarction

Jairo T Nunes et al. J Am Heart Assoc. .
No abstract available

Keywords: Editorials; acute myocardial infarction; heart failure; sodium‐glucose cotransporter‐2 inhibitors.

PubMed Disclaimer

Comment on

References

    1. Udell JA, Jones WS, Petrie MC, Harrington JL, Anker S, Bhatt DL, Hannan K, Vedin O, Hernandez AF, Butler J. Sodium glucose cotransporter‐2 inhibition for acute myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2022;79:2058–2068. doi: 10.1016/j.jacc.2022.03.353 - DOI - PMC - PubMed
    1. Harrington J, Petrie MC, Anker SD, Bhatt DL, Jones WS, Udell JA, Hernandez AF, Butler J. Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction: a review. JAMA Cardiol. 2022;7:1067–1075. doi: 10.1001/jamacardio.2022.2847 - DOI - PubMed
    1. Harrington JL, Jones WS, Udell JA, Hannan K, Bhatt DL, Anker S, Petrie MC, Vedin O, Butler J, Hernandez AF. Acute decompensated heart failure in the setting of acute coronary syndrome. JACC Heart Fail. 2022;10:404–414. doi: 10.1016/j.jchf.2022.02.008 - DOI - PubMed
    1. Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–2128. doi: 10.1056/NEJMoa1504720 - DOI - PubMed
    1. Wiviott SD, Raz I, Sabatine MS. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:1881–1882. doi: 10.1056/NEJMc1902837 - DOI - PubMed

MeSH terms

Substances